Anna Vardeleon

Statistics

Publications

Citations

240

H-Index

Active since

2006

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Anna Vardeleon is an author at The University of Texas MD Anderson Cancer Center specializing in pharmacology, cancer pharmacology, and metastatic melanoma treatment.

Publications per year

2006–2012

Publications

A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma

Kevin B. Kim, Víctor G. Prieto, Richard W. Joseph et al. · Melanoma Research · 2012 · 75 citations · Full text

Medicine, Oncology, Pharmacology +14

Pharmacokinetics and Urinary Excretion of Vincristine Sulfate Liposomes Injection in Metastatic Melanoma Patients

Agop Y. Bedikian, Anna Vardeleon, Teresa Smith et al. · The Journal of Clinical Pharmacology · 2006 · 52 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetics and Safety of Marqibo (Vincristine Sulfate Liposomes Injection) in Cancer Patients With Impaired Liver Function

Agop Y. Bedikian, Jeffrey A. Silverman, Nicholas E. Papadopoulos et al. · The Journal of Clinical Pharmacology · 2010 · 42 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

A phase II study of gefitinib in patients with metastatic melanoma

Sapna P. Patel, Kevin B. Kim, Nicholas E. Papadopoulos et al. · Melanoma Research · 2011 · 41 citations

Medicine, Oncology, Pharmacology +17

A pilot study with vincristine sulfate liposome infusion in patients with metastatic melanoma

Agop Y. Bedikian, Nicholas E. Papadopoulos, Kevin B. Kim et al. · Melanoma Research · 2008 · 30 citations

Medicine, Oncology, Pharmacology +17

1–5 of 5